| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108778332-B |
| titleOfInvention |
PD-1 antibody is combined with IDO inhibitor is preparing the purposes in anti-tumor drug |
| abstract |
Combine the invention discloses PD-1 antibody or its antigen-binding fragment with IDO inhibitor and is preparing the purposes in anti-tumor drug. |
| priorityDate |
2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |